The largest database of trusted experimental protocols

Pet ct scanner

Manufactured by GE Healthcare
Sourced in United States

The PET/CT scanner is a medical imaging device that combines positron emission tomography (PET) and computed tomography (CT) technologies. It is designed to produce detailed images of the body's internal structures and functions. The PET component detects the emission of positrons from radioactive substances introduced into the body, while the CT component provides high-resolution anatomical images. The combined data from these two imaging modalities is then processed and displayed to assist healthcare professionals in the diagnosis and management of various medical conditions.

Automatically generated - may contain errors

35 protocols using pet ct scanner

1

Multi-modal PET and MRI Neuroimaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All PET scans were acquired using a PET/CT scanner (GE Healthcare, Milwaukee, Wisconsin) operating in 3D mode. For tau-PET, an intravenous bolus injection of approximately 370 MBq (range 333–407 MBq) of [18F]AV-1451 was administered, followed by a 20 minute PET acquisition performed 80 min after injection. For Aβ-PET, participants were injected with Pittsburgh Compound B (PiB) of approximately 628 MBq (range, 385–723 MBq) and, after a 40–60 minute uptake period, a 20 minute PiB scan was obtained. Both PiB and [18F]AV-1451 scans consisted of four 5-minute dynamic frames following a low dose CT transmission scan. Standard corrections were applied. Emission data were reconstructed into a 256 × 256 matrix with a 30-cm FOV (in-plane pixel size = 1.0 mm, slice thickness = 1.96 mm). All participants underwent a 3 T head MRI protocol that included a magnetization prepared rapid gradient echo (MPRAGE) sequence (TR/TE/TI, 2300/3/900 ms; flip angle 8°, 26-cm field of view (FOV); 256 × 256 in-plane matrix with a phase FOV of 0.94, and slice thickness of 1.2 mm (Jack Jr. et al., 2008 (link)) and a fluid-attenuated inversion recovery (FLAIR) (TR/TE = 11,000/147 ms; 22-cm FOV; slice thickness = 3.6 mm) sequence. White matter hyperintensities were segmented and manually edited on the FLAIR images by a trained image analyst using a semi-automated method (Table 1) (Raz et al., 2013 (link)).
+ Open protocol
+ Expand
2

Standardized 3D FDG PET/CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
As part of a standardized protocol, all participants had 3.0 T MR imaging which included a 3-D MPRAGE sequence, as well as FDG PET/CT imaging using a PET/CT scanner (GE Healthcare) operating in 3D mode. Details of the imaging protocols have been described previously [2 (link), 3 (link)]. Individual participant level maps of hypometabolism were generated using 3-dimensional stereotactic surface projections with CortexID (GE Healthcare, Waukesha, WI, USA). This is a fully automated analysis including realignment, spatial normalization, non-linear warping, followed by sampling of 16,000 predefined cortical locations which are then projected onto a 3D brain surface. Participant PET data is normalized to the pons and compared to a normative database, resulting in a 3D stereotactic surface projections Z-score image. These images were analyzed visually and quantitatively as outlined below.
+ Open protocol
+ Expand
3

FDG-PET Analysis of PPA Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
FDG-PET scans were acquired using a PET/CT scanner (GE Healthcare, Milwaukee, Wisconsin) as previously described (Josephs et al., 2012 (link)). Individual patterns of hypometabolism were assessed using the clinical tool of 3-dimensional stereotactic surface projections (SSP) (Minoshima, Frey, Koeppe, Foster, & Kuhl, 1995 (link)) as implemented in the CortexID software package (GE Healthcare, Waukesha, Wisconsin). Activity was normalized to the pons and compared with an age-stratified normative database, yielding a 3-dimensional SSP z score image. Regional FDG-PET metabolism in both the gray and white matter was calculated with the MCALT (Schwarz et al., 2017 ). For this study, regions-of-interest (ROIs) were selected a priori based on regions that are typically affected in the three PPA variants (Bouwman et al., 2018 (link); Guo et al., 2016 (link); Josephs, Duffy, Fossett, & et al., 2010; Matias-Guiu, Cabrera-Martín, Matías-Guiu, & Carreras, 2017 (link); Nestor et al., 2018 (link); Sonty et al., 2003 ) and included the following regions, keeping the left and right hemispheres separate: inferior frontal (combined opercularis, triangularis, and orbitalis), medial temporal, lateral temporal, lateral parietal, sensorimotor region (combined supplementary motor area and precentral), and cerebellum (combined cortical cerebellar regions).
+ Open protocol
+ Expand
4

FDG and PiB PET Imaging Protocol for Alzheimer's Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
All PET scans were acquired using a GE PET/CT scanner. Participants were injected with FDG (average, 459 MBq; range, 367–576 MBq) and following a 30-minute uptake period, an 8-minute scan was administered utilizing four 2-minute dynamic frames [2 (link)] [26 (link)]. Participants were injected with PiB of approximately 628 MBq (range, 385–723 MBq) and after a 40-to-60-minute uptake period, a 20-minute scan was obtained. Standard corrections were adjusted for and data were reconstructed into a 256×256 matrix with a 30-cm field of view (image thickness=3.75 mm) [2 (link)]. If motion was detected single frames of the PET were realigned and a mean image created [16 (link)]. A global PiB standard uptake value ratio (SUVR) was calculated as previously described [27 (link)], with a cut-point of ≥1.48 used to determine beta-amyloid positivity. All participants also underwent a volumetric head MRI within one day of the FDG-PET that included a magnetization-prepared rapid acquisition gradient echo (MPRAGE) sequence.
+ Open protocol
+ Expand
5

Multimodal Neuroimaging and EEG Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
MRI images were acquired at 3T and included a combination structural T2-weighted, diffusion-weighted imaging (DWI) and fluid attenuation inversion recovery (FLAIR) acquisition sequences.
FDG-PET images were acquired using a PET/CT scanner (GE Healthcare). Patients were injected with FDG in a dimly lit room and waited for a 30-minutes uptake period. FDG scans lasted 8 minutes, separated into four 2-minutes dynamic frames following a low-dose CT transmission scan. Images were processed through CortexID software. Standardized uptake value ratios (SUVRs) were calculated by normalizing regional glucose uptake to the pons and were compared with an age-segmented normative database using Z scores.
EEG evaluations consisted of 30–60-minute recordings with a 19-channel digital EEG machine with standard activating procedure. The standard ‘10–20 System’ procedure was used for the positioning of electrodes.
+ Open protocol
+ Expand
6

Effect of Hair on PET/MR Attenuation Correction

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of hair was quantified for the subject shown in Fig. 2d–f who had hair clearly visible around the head. A manual ROI was drawn on each transverse slice of the CT to carefully remove the hair without removing any of the scalp. The PET scan of this subject, acquired on the mMR, was attenuation-corrected using the CT with the hair included and alternatively using the CT with the hair cropped out of the image.
The effect of hair was also indirectly assessed on 14 subjects as part of an evaluation of a state-of-the-art atlas-based MRAC method called MaxProb [6 (link)], undertaken at our institution. MaxProb outperformed the UTE and Dixon-based segmentation methods implemented on the mMR and was one of the best performing brain attenuation correction methods reported by Ladefoged et al. [12 (link)]. The method generates a pseudo-CT image through the registration of a database of aligned MRI and CT image pairs with a T1-weighted MRI image acquired as part of the PET-MR scanning protocol. Hair is not included in the pseudo-CT image—all pixels located outside the boundary between air and the patient’s scalp are assigned an LAC value of zero. For each subject, an image was generated of the percentage difference between a static PET image attenuation-corrected using the CT-derived μ-map from a GE PET CT scanner and an image reconstructed using a pseudo-CT generated by MaxProb.
+ Open protocol
+ Expand
7

Alzheimer's Disease Neuroimaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All participants were part of the Mayo ADRC and agreed to undergo brain magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography (18F-FDG-PET) imaging. All recent MRIs were performed with a 3.0 T with additional 3-D MPRAGE sequences. 18F-FDG-PET images were acquired using a PET/CT scanner (GE Healthcare) operating in 3D mode. Participants were injected in a dimly lit room with 18F-FDG, and after a 30-minute uptake period, an 8-minute 18F-FDG scan was performed, which consisted of four 2-minute dynamic frames following a low dose CT transmission scan. Standard acquisition and vendor reconstruction parameters were used. 18F-FDG-PET scans were processed using CortexID software (GE Healthcare). The activity in each participant’s PET dataset was normalized to the pons and compared with an age-segmented normative database, yielding z-score 3D-stereotactic surface projection (SSP) images.
+ Open protocol
+ Expand
8

Multimodal Brain Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients underwent MRI, 18-F fluorodeoxyglucose (FDG) and PiB PET scanning within two days of the clinical evaluations. The MRI imaging protocol was performed on a 3T GE scanner, and included a 3D magnetization prepared rapid acquisition gradient echo (MPRAGE) sequence and a diffusion tensor imaging (DTI) sequence with 41 diffusion encoding steps and four non-diffusion (b0) weighted T2 images. All PET scans were acquired using a PET/CT scanner (GE Healthcare, Milwaukee, Wisconsin) operating in 3D mode. Detailed acquisition details have been previously published (Josephs et al., 2012 (link)).
+ Open protocol
+ Expand
9

Multimodal Neuroimaging of Cerebral Amyloid

Check if the same lab product or an alternative is used in the 5 most similar protocols
All MRI examinations were performed at 3T (GE Healthcare) MRI scanners. The complete details of the acquisitions were previously published [16 (link)]. A T2* GRE MRI was performed with the following parameters: (repetition time/echo time = 200/20 ms; flip angle = 12°; in-plane matrix = 256 × 224; phase field of view = 1.00; slice thickness = 3.3 mm; acquisition time, 5 min) [17 (link)]. CMBs were identified by trained image analysts and confirmed by a cerebrovascular neurologist or radiologist. CMBs were considered lobar, deep/infratentorial or cerebellar in location [17 (link), 18 (link)].
Aβ-PET imaging was performed with Pittsburgh Compound B [19 (link)]. PET images were acquired using a PET/CT scanner (GE Healthcare). Details of PET acquisition have been previously published [20 (link)]. Aβ PET images were analyzed with our in-house, fully automated image processing pipeline wherein image voxel values are extracted from automatically labeled regions of interest (ROIs) propagated from an MRI template [21 (link)]. Global Aβ-PET SUVr was calculated as the median uptake in the prefrontal, orbitofrontal, parietal, temporal, anterior and posterior cingulate and precuneus ROIs normalized to the median cerebellar crus gray matter.
+ Open protocol
+ Expand
10

Asymmetric Temporal Lobe Metabolism in SDM

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FDG-PET scans were acquired using a PET/CT scanner (GE Healthcare, Milwaukee, WI, USA) operating in 3D mode. Prior to injection, all participants were required to fast for a period of six hours. Participants were injected with 18F-FDG of ∼459 MBq (range 367–576 MBq). After injection, all participants were placed in a dimly lit room for 30 minutes, with minimal auditory stimulation. After the 30 minutes, an 8-minute scan was performed. FDG-PET consisted of four 2-minute dynamic frames acquired from 30 to 38 minutes after injection. PET sinograms were iteratively reconstructed into a 256-mm field of view (FOV). The pixel size was 1.0 mm and the slice thickness was 3.3 mm. Standard corrections were applied. Individual-level patterns of hypometabolism were assessed using a 3D stereotactic surface projections with CortexID Suite (GE Healthcare), whereby activity at each voxel was normalized to the pons and Z-scored to an age-segmented normative database. Average medial temporal and lateral temporal Z-scores (with negative scores representing hypometabolism) were calculated and compared between the left and right hemispheres. Participants were assigned to the lpSMD or rpSDM group based on the finding of at least 0.5 differences in medial and/or lateral temporal Z-scores between the left and right hemispheres.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!